Market Research Logo

United States Cardiovascular Surgery Devices Market Outlook to 2025

United States Cardiovascular Surgery Devices Market Outlook to 2025

Summary

GlobalData’s new report, United States Cardiovascular Surgery Devices Market Outlook to 2025, provides key market data on the United States Cardiovascular Surgery Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment, Chest Drainage Catheters and Units and Perfusion Disposables.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Cardiovascular Surgery Devices market segments - Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment, Chest Drainage Catheters and Units and Perfusion Disposables.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Cardiovascular Surgery Devices market.
  • Global corporate-level profiles of key companies operating within the United States Cardiovascular Surgery Devices market.
  • Key players covered include Medtronic plc, LivaNova PLC, Terumo Corp. and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cardiovascular Surgery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cardiovascular Surgery Devices Market, United States
3.1 Cardiovascular Surgery Devices Market, United States, Revenue ($m), 2015-2025
3.1.1 Beating Heart Surgery Systems Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.2 Chest Drainage Catheters and Units Market, United States, Revenue ($m), by Segment, 2015-2025
3.1.3 Perfusion Disposables Market, United States, Revenue ($m), by Segment, 2015-2025
3.2 Cardiovascular Surgery Devices Market, United States, Volume (Units), 2015-2025
3.2.1 Beating Heart Surgery Systems Market, United States, Volume (Units), by Segment, 2015-2025
3.2.2 Chest Drainage Catheters and Units Market, United States, Volume (Units), by Segment, 2015-2025
3.2.3 Perfusion Disposables Market, United States, Volume (Units), by Segment, 2015-2025
3.3 Cardiovascular Surgery Devices Market, United States, Average Price ($), 2015-2025
3.4 Cardiovascular Surgery Devices Market, United States, Distribution Share by Revenue ($m), 2017
3.5 Cardiovascular Surgery Devices Market, United States, Company Share by Revenue ($m), 2017
4 Overview of Key Companies in United States, Cardiovascular Surgery Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 LivaNova PLC
4.2.1 Company Overview
4.3 Terumo Corp
4.3.1 Company Overview
4.4 Getinge AB
4.4.1 Company Overview
4.5 Teleflex Inc
4.5.1 Company Overview
4.6 Rocket Medical Plc
4.6.1 Company Overview
4.7 Cook Medical Inc
4.7.1 Company Overview
5 Cardiovascular Surgery Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 LivaNova to Acquire CardiacAssist
6.1.2 Edwards Lifesciences Acquires Harpoon Medical
6.1.3 MiMedx Sells its Stability Biologics
6.1.4 Amendia Acquires Spinal Elements
6.2 Asset Transactions
6.2.1 Aesculap Acquires All Assets from Dextera Surgical for USD17.3 Million
6.3 Debt Offerings
6.3.1 Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028
6.4 Equity Offerings
6.4.1 Dextera Surgical Raises USD8 Million in Public Offering of Series B Preferred Stock and Warrants
6.5 Venture Financing
6.5.1 Peca Labs Raises USD1.4 Million in Venture Financing
6.5.2 Morris Innovative Raises USD3.5 Million in Venture Financing
6.5.3 Bioventrix Raises USD1.3 Million in Venture Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jan 10, 2018: Spine Industry Veteran Paul Graveline Joins Spinal Elements
7.1.2 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
7.1.3 Oct 02, 2017: Jeffrey H. Burbank Joins CryoLife Board of Directors
7.1.4 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017
7.1.5 Jul 24, 2017: EndoGastric Solutions Expands Commercial Leadership Team to Meet Increased Demand for TIF Procedure for Reflux
7.1.6 Jul 11, 2017: Spinal Elements Promotes Jason Blain to President & Chief Operating Officer
7.1.7 Jun 28, 2017: Living Values, Aligning Action: Medline Amplifies Commitment to Socially Responsible Business Growth and Impact
7.1.8 May 31, 2017: Southern Research Taps Lillie Ryans As Director Of Contracts
7.1.9 May 26, 2017: Merit Medical Announces Appointment of New Director
7.1.10 May 18, 2017: Edwards Lifesciences' Every Heartbeat Matters Initiative On Track To Impact 1 Million Underserved People By 2020
7.1.11 May 02, 2017: Medline Names New President of Canadian Business
7.1.12 Apr 06, 2017: Terumo Cardiovascular Group Announces New President and CEO, Robert DeRyke
7.2 Financial Announcements
7.2.1 Mar 15, 2018: MiMedx Announces Expectation to Exceed the $92 Million Top End of First Quarter Revenue Guidance
7.2.2 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results
7.2.3 Feb 27, 2018: Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results
7.2.4 Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017
7.2.5 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance
7.2.6 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
7.2.7 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results
7.2.8 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
7.2.9 Jan 08, 2018: Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Result
7.2.10 Jan 07, 2018: MiMedx Releases Preliminary 2017 Revenue of $324.5M Representing a 32% Increase Over 2016
7.2.11 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
7.2.12 Nov 09, 2017: Dextera Surgical Reports Fiscal 2018 First Quarter Financial Results
7.2.13 Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance
7.2.14 Oct 30, 2017: CryoLife Reports Third Quarter 2017 Results
7.2.15 Oct 26, 2017: LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%)
7.2.16 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
7.2.17 Oct 26, 2017: MiMedx Announces Record Results For Third Quarter Of 2017 And Raises Full Year Revenue Guidance
7.2.18 Oct 26, 2017: Integra LifeSciences Reports Third Quarter 2017 Financial Results
7.2.19 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017
7.2.20 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results
7.2.21 Oct 10, 2017: MiMedx Announces Third Quarter Revenues Of $84.6 Million Exceeds Guidance By More Than 5 Percent
7.2.22 Aug 08, 2017: Dextera Surgical Reports Fiscal 2017 Fourth Quarter Financial Results
7.2.23 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance
7.2.24 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%)
7.2.25 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
7.2.26 Jul 26, 2017: MiMedx Announces Record Results For The Second Quarter Of 2017 And Raises Full Year Revenue Guidance
7.2.27 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results
7.2.28 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance
7.2.29 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results
7.2.30 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results
7.2.31 Jul 13, 2017: MiMedx Announces that its Second Quarter Revenue Exceeds the Guidance Range
7.2.32 Jul 13, 2017: CareDx provides 100,000th AlloMap to heart transplant patients
7.2.33 May 04, 2017: Dextera Surgical Reports Fiscal 2017 Third Quarter Financial Results
7.2.34 Apr 28, 2017: MiMedx Announces Record Results For First Quarter Of 2017
7.2.35 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
7.2.36 Apr 27, 2017: Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance
7.2.37 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017
7.2.38 Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%)
7.2.39 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results
7.2.40 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results
7.2.41 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results
7.2.42 Apr 24, 2017: Dextera Surgical Announces Preliminary Fiscal 2017 Third Quarter Financial Highlights
7.2.43 Apr 17, 2017: Surmodics Appoints Lisa Wipperman Heine to Its Board of Directors
7.2.44 Apr 13, 2017: MiMedx Announces First Quarter 2017 Revenue to Exceed High End of Guidance
7.3 Government and Public Interest
7.3.1 Feb 13, 2018: Multidisciplinary Team Completes First-Ever EXIT to Ventricular Pacing Procedure
7.4 Legal And Regulatory
7.4.1 Mar 02, 2018: MiMedx Receives Notice of Filing Delinquency from NASDAQ
7.4.2 Jan 11, 2018: MiMedx Obtains Successful Settlement Of Its Patent Infringement Lawsuit Against Musculoskeletal Transplant Foundation, Medline Industries And Liventa Bioscience
7.4.3 Nov 01, 2017: MiMedx Agrees To Lawsuit Settlement With Halo Wound Solutions
7.4.4 Oct 04, 2017: MiMedx Files Lawsuit Related To Short Seller Attacks
7.4.5 Oct 02, 2017: Court Sets the Trial Date for MiMedx Patent Infringement Lawsuit Against MTF, Medline and Liventa
7.4.6 Sep 21, 2017: MiMedx Files Lawsuit Against The Capitol Forum
7.4.7 Sep 18, 2017: MiMedx Patent Infringement Lawsuit Updates
7.5 Other Significant Developments
7.5.1 Dec 22, 2017: NYU Langone To Offer Heart Transplant Services At NYU Winthrop Hospital On Long Island
7.5.2 Oct 05, 2017: Dextera Surgical Provides Corporate Update
7.5.3 Sep 26, 2017: Integra LifeSciences Provides Preliminary Assessment of Minor Damage to its Manufacturing Facility in Anasco, Puerto Rico
7.5.4 Sep 13, 2017: MiMedx Reiterates Its Third Quarter Revenue Expectation To Exceed $80 Million Despite Hurricane Irma
7.5.5 Aug 30, 2017: Medline Remains Operational Through Hurricane Harvey and Current Recovery
7.5.6 Jul 05, 2017: MiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down
7.5.7 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
7.5.8 Apr 25, 2017: AtriCure's AtriClip System Surpasses 100,000 Units Sold Worldwide
7.5.9 Apr 03, 2017: Mallinckrodt Statement on DEA and USAOs Agreement in Principle
7.6 Product News
7.6.1 Mar 05, 2018: Engineers, physicians team to replace heart valves using personalized modeling
7.6.2 Oct 24, 2017: SentreHEART Announces Participation at Transcatheter Cardiovascular Therapeutics 2017
7.6.3 Aug 03, 2017: Cutting-Edge Treatment for Severe Stroke at NYC Health + Hospitals/Kings County Is Saving Patients’ Lives
7.6.4 Jun 12, 2017: Dextera Surgical’s MicroCutter 5/80 and Cardiac Anastomosis Devices Featured at International Society for Minimally Invasive Cardiothoracic Surgery Conference
7.7 Strategy And Business Planning
7.7.1 Nov 27, 2017: Spinal Elements Announces Headquarters and CEO Changes
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Cardiovascular Surgery Devices Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Cardiovascular Surgery Devices Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Chest Drainage Catheters and Units Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Chest Drainage Catheters and Units Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 8: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 9: Cardiovascular Surgery Devices Market, United States, Volume (Units), 2015-2020
Table 10: Cardiovascular Surgery Devices Market, United States, Volume (Units), 2021-2025
Table 11: Beating Heart Surgery Systems Market, United States, Volume (Units), 2015-2020
Table 12: Beating Heart Surgery Systems Market, United States, Volume (Units), 2021-2025
Table 13: Chest Drainage Catheters and Units Market, United States, Volume (Units), 2015-2020
Table 14: Chest Drainage Catheters and Units Market, United States, Volume (Units), 2021-2025
Table 15: Perfusion Disposables Market, United States, Volume (Units), 2015-2020
Table 16: Perfusion Disposables Market, United States, Volume (Units), 2021-2025
Table 17: Cardiovascular Surgery Devices Market, United States, Average Price ($), 2015-2020
Table 18: Cardiovascular Surgery Devices Market, United States, Average Price ($), 2021-2025
Table 19: Cardiovascular Surgery Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 20: Cardiovascular Surgery Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 21: Cardiovascular Surgery Devices Market Pipeline Products
Table 22: LivaNova to Acquire CardiacAssist
Table 23: Edwards Lifesciences Acquires Harpoon Medical
Table 24: MiMedx Sells its Stability Biologics
Table 25: Amendia Acquires Spinal Elements
Table 26: Aesculap Acquires All Assets from Dextera Surgical for USD17.3 Million
Table 27: Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028
Table 28: Dextera Surgical Raises USD8 Million in Public Offering of Series B Preferred Stock and Warrants
Table 29: Peca Labs Raises USD1.4 Million in Venture Financing
Table 30: Morris Innovative Raises USD3.5 Million in Venture Financing
Table 31: Bioventrix Raises USD1.3 Million in Venture Financing
Table 32: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country
1.2 List of Figures
Figure 1: Cardiovascular Surgery Devices Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Beating Heart Surgery Systems Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Chest Drainage Catheters and Units Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Perfusion Disposables Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 5: Cardiovascular Surgery Devices Market, United States, Volume (Units), 2015-2025
Figure 6: Beating Heart Surgery Systems Market, United States, Volume (Units), 2015-2025
Figure 7: Chest Drainage Catheters and Units Market, United States, Volume (Units), 2015-2025
Figure 8: Perfusion Disposables Market, United States, Volume (Units), 2015-2025
Figure 9: Cardiovascular Surgery Devices Market, United States, Company Share (%) 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report